Table 1.
Transcription factors |
Expression | Cell fate and differentia tion actions |
Trans cr. role |
DNA-binding motif |
Human skeletal diseases |
||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
S S C |
P C |
E C |
C C |
P H C |
H C |
T C |
per iC |
J P |
A C C |
O B |
|||||
1. Beta-scaffold transcription factors with minor groove contacts | |||||||||||||||
| |||||||||||||||
1.1. HMG-domain transcription factors | |||||||||||||||
1.1.1. SOX transcription factors | |||||||||||||||
SOX9 | + | + | + | + | + | + | + | + | − | Master activator of the PC to the HC and ACC stages | TA (TR) | [T/A][T/A]CAA[T/A]G[n3-4] C[A/T]TTG[A/T][A/T] |
Campomelic dysplasia | ||
SOX5/SOX6 | − | + | + | + | + | + | + | Promote EC, CC, HC, and ACC differentiation | help in TA | ATTGTT[nN]ATTGTT | LAMSHF syndrome (SOX5) | ||||
SOX8 | + | + | + | + | + | (A/T)(A/T)CAA(A/T)G | |||||||||
SOX4/SOX11/SOX12 | + | + | + | + | + | + | + | + | + | + | Promote cell survival, SSC/JP non-chondrogenic fate, and CC alignment | TA | AACAA | Coffin-Siris syndrome (SOX11) | |
1.1.2. TCF/LEF transcription factors | |||||||||||||||
TCF7L2 | + | Promotes HC differentiation | TA | CTTTG[A/T][A/T] | |||||||||||
1.2. RUNX transcription factors | |||||||||||||||
RUNX1/2/3 | + | + | + | + | + | + | + | + | + | Master activators of the PHC to TC stages | TA | [A/G]ACC[A/G]CA | Cleidocranial dysplasia (RUNX2) | ||
1.3. MADS-domain transcription factors | |||||||||||||||
MEF2C/D | + | + | + | + | Activators of the PHC to TC stages | TA | CC[A/T]6GG | ||||||||
1.4. REL-homology-domain (RHD) transcription factors | |||||||||||||||
RELA/p65 | + | + | + | + | + | + | Promotes SSC and GPC survival and proliferation | TA | GGG[A/G]n[C/T][C/T][C/T]CC | ||||||
NFATC1/2/3 | + | + | + | + | Promote ACC maintenance | TA | GGAAA | ||||||||
1.5. STAT transcription factors | |||||||||||||||
STAT1 and STAT5 | + | + | + | + | + | + | + | + | + | + | + | Inhibit CC proliferation | TA | TTC[N2–4]GAA | |
| |||||||||||||||
2. Zinc-coordinating transcription factors | |||||||||||||||
| |||||||||||||||
2.1. C2H2 zinc-finger transcription factors | |||||||||||||||
SP1 | + | + | + | + | + | + | + | + | + | + | + | TA | GGCGGGG | ||
SP7 | + | + | + | + | Promotes TC differentiation | TA | GGCGGGG | ||||||||
ZNF521/ZFP521 | + | + | + | Slows down CC to PHCs/HC transition | TR | ||||||||||
ZBTB20/ZNF288 | + | + | + | + | Inhibits chondrocyte hypertrophy | TR | Primrose syndrome | ||||||||
SNAI1 and SNAI2 | + | + | + | + | + | + | + | + | + | + | Promote CC proliferation and PHC/HC differentiation | TR | CAGGTG | ||
GLI1 to 3 | + | + | + | + | + | + | + | + | Mediator/Inhibitor of Hedgehog signaling | TA/TR | |||||
2.2. C4 zinc-finger of nuclear receptor- type | |||||||||||||||
Glucocorticoid receptor | + | + | + | + | + | + | + | + | + | + | + | Dispensable in normal conditions | TA/TR | AGAACA[n3]TGTTCT | |
Thyroid hormone receptors α and β | + | + | + | + | + | Accelerates (NR1A1) and inhibits (NR1A2) GPC maturation | TA/TR | AGGTCA[n4]TGACCT | |||||||
Retinoic acid receptors α, β and γ | + | + | + | + | Enhance CC proliferation and matrix production | TA/TR | AGGTCA[n5]AGACCA | ||||||||
Peroxisome proliferator-activated receptors α, β/δ and γ | + | + | + | + | Enhances GPC gene expression (PPARG) | TA/TR | AGGTCA | ||||||||
2.3. Diverse C4-type zinc-finger transcription factors | |||||||||||||||
GATA6 | + | + | Inhibits ectopic expression of Shh in SSCs | TA | [A/T]GATA[A/G] | ||||||||||
TRPS1 | + | + | + | + | + | + | Facilitates PHC to HC transition | TR | [A/T]GATA[A/G] | Tricho-Rhino-Phalangeal syndrome | |||||
| |||||||||||||||
3. Helix-turn-helix transcription factors | |||||||||||||||
| |||||||||||||||
3.1. Homeodomain transcription factors | |||||||||||||||
HOX family | + | + | Specify skeletal element identity and early patterning | TA | (C/G)TAATTG | Synpolydactyly; hand-foot-genital syndrome | |||||||||
SHOX and SHOX2 | + | + | Delay GPC maturation non-cell-autonomously | TA | Leri-Weill dyschondrosteosis and Langer mesomelic dysplasia | ||||||||||
PRRX1 | + | + | Contributes to skeletal early patterning | TA | AATTA | Agnathia-otocephaly | |||||||||
DLX5/DLX6 | + | + | + | + | + | Promote PHC/HC differentiation | TA | [C/T]AATT[A/T] | Split-hand/foot malformation syndrome | ||||||
NKX3.2/BAPX1 | + | + | + | + | Promotes EC differentiation; represses GPC and ACC maturation | TR | TTAATTG | Spondylo-megaepiphyseal-metaphyseal dysplasia | |||||||
3.2. Paired-domain transcription factor | |||||||||||||||
PAX1/PAX9 | + | + | Support cell survival | TA/TR | GTCACGGT | ||||||||||
3.3. Forkhead-domain transcription factors | |||||||||||||||
FOXC1/FOXC2 | + | + | + | + | + | + | + | Contribute to skeletal patterning; promote endochondral ossification | TA | [A/C]AA[C/T] | |||||
FOXA2/FOXA3 | + | + | + | Promote HC differentiation | TA | [A/C]AA[C/T] | |||||||||
FOXP1/FOXP2/FOXP4 | + | + | + | + | Delay GP maturation and EO | TR | T[G/A]TTTAC[T/A[T/C][T/A] | ||||||||
FOXO1/FOXO3/FOXO4 | + | + | + | + | + | + | + | + | + | + | + | Promote TC maturation | TA | [T/G]TAAACA[A/T] | |
3.4. Tryptophan cluster transcription factors | |||||||||||||||
ERG | + | + | + | Promotes AC homeostasis | TA | ACAGGAA[G/A] | |||||||||
| |||||||||||||||
4. Basic-domain transcription factors | |||||||||||||||
| |||||||||||||||
4.1. Basic helix-loop-helix (bHLH) transcription factors | |||||||||||||||
TWIST1 | + | + | Prevents SSC differentiation into skeletal cells | TR | CANNTG, E-box | Saethre-Chotzen syndrome | |||||||||
HIF1α/2α | + | + | + | + | + | + | + | + | + | + | + | Promote JP and GPC survival and differentiation | TA | CANNTG, E-box | |
HES and HEY | + | + | + | + | + | + | Delay EC differentiation; promote HC differentiation | TR | CACGTGC | ||||||
SREBP1/2 | + | + | + | + | + | + | + | + | + | + | + | Essential for lipid homeostasis | TA | ACTACANNTCCC | |
4.2. Basic leucine-zipper (bZIP) transcription factors | |||||||||||||||
4.2.1. ATF/CREB family | TA/TR | GTGACGT[A/C][A/G] | |||||||||||||
ATF4/ATF3 | + | + | + | + | + | + | + | + | + | + | + | Promote CC proliferation and PHC differentiation | |||
ATF2 and CREB | + | + | + | + | + | + | + | + | + | + | + | Promote CC proliferation | |||
ATF6 | + | + | + | + | Promotes HC differentiation | ||||||||||
BBF2H7 | + | + | + | Promotes CC proliferation and PHC differentiation | |||||||||||
4.2.2. AP1 family | TA | (TGA[G/C]TCA) or TGACGTCA | |||||||||||||
cJUN | + | + | + | + | + | + | Represses the chondrogenic fate in JPs; may promote GPC maturation | ||||||||
FOS | + | + | Delays HC differentiation | ||||||||||||
FOSL2 | + | + | + | + | + | Promotes HC differentiation | |||||||||
4.2.3. MAF family | |||||||||||||||
c-MAF and MAF-B | + | + | + | + | Promote endochondral ossification | Multicentric carpotarsal osteolysis syndrome (MAFB) | |||||||||
4.2.4. CCAAT-enhancer-binding protein family | |||||||||||||||
C/EBPβ and C/EBPδ | + | + | + | + | + | + | + | + | + | + | + | Promote PHC/HC differentiation | |||
4.3. Basic leucine-zipper (bZIP) transcription factors | |||||||||||||||
4.3.1. AP2 family | GTCGGTG | ||||||||||||||
AP2α, β, and γ | + | + | + | + | + | SSC survival and proliferation; delay GPC maturation | |||||||||
AP2ε | + | + | + | Repress Col2a1 expression in HC | |||||||||||
| |||||||||||||||
5. Transcription factors with a β-hairpin exposed by a α/β-scaffold | |||||||||||||||
| |||||||||||||||
NFIC/X | + | + | + | + | + | + | + | + | + | + | + | Promote endochondral ossification | TA/TR | TTGGC(N5)GCCAA | Marshall-Smith and Sotos syndromes |
SMAD1 to 9 | + | + | + | + | + | + | + | + | + | + | + | Promote chondrogenesis at virtually every step | TA/TR | GC-rich motifs (CTGGAGCC) |
Abbreviations: ACC, articular chondrocyte; CC, columnar chondrocyte; EC, early chondrocyte; EO, endochondral ossification; GP, growth plate; GPC, growth plate chondrocyte; HC, hypertrophic chondrocyte; JP, joint progenitor cells; OB, osteoblast; PeriC, perichondrium cell; PC, prechondrocyte; PHC, prehypertrophic chondrocyte; SSC, skeletal progenitor/stem cell; TC, terminal chondrocyte; TA, trancriptional activator; TR, transcriptional repressor